NHC PE Ratio & Valuation, Is NHC Overvalued
This article analyzes the valuation of National Healthcare Corp (NHC), stating that it is currently in the "Fair zone" based on its forward PS ratio compared to its five-year average. It details NHC's Price-to-Book ratio, Free Cash Flow yield, and compares its P/S ratio to competitor averages, suggesting that some premiums might be unsustainable given its revenue growth. The article also provides answers to frequently asked questions regarding NHC's valuation metrics as of April 1, 2026.
Vanguard disaggregates holdings; NHC (NYSE: NHC) shows 0 shares in amendment
The Vanguard Group has filed an amended Schedule 13G/A for National HealthCare Corp (NHC), reporting 0 shares beneficially owned and 0% of the class. This change is due to an internal realignment on January 12, 2026, where Vanguard's subsidiaries and divisions will now report their holdings separately, in accordance with SEC Release No. 34-39538. The filing, signed by Ashley Grim, Head of Global Fund Administration, indicates a compliance adjustment rather than an economic sale or change in investment strategy.
NATIONAL HEALTHCARE (NHC) SVP exercises options and uses shares for taxes
NATIONAL HEALTHCARE CORP (NHC) Senior Vice President Vicki L. Dodson exercised stock options for 3,734 shares, increasing her direct holdings. Shares were withheld by the company to cover the exercise price and related tax obligations, rather than an open-market sale. Following these transactions, Ms. Dodson directly owns 14,412.5455 shares and retains several other stock option grants.
National Healthcare Corp (NHC) CEO gains 1,853 shares via option exercise
National Healthcare Corp (NHC) CEO Stephen Fowler Flatt exercised stock options to acquire 1,853 shares of common stock at $53.94 per share. This transaction, exempt under Rule 16b-3(d), increased his direct holdings to 65,505 shares. Flatt still holds options for an additional 43,000 shares expiring between 2029 and 2031.
CFO of National HealthCare (NYSE: NHC) exercises 1,853 options
National HealthCare Corp's SVP and CFO, Brian F. Kidd, exercised stock options for 1,853 shares at $53.94 per share, granted under the 2020 Omnibus Equity Incentive Plan. Following this transaction, Kidd directly holds 29,130 shares and still possesses options for an additional 31,500 shares with various exercise prices and expiration dates through 2031. This transaction was reported via a Form 4 SEC filing, indicating an option exercise rather than an open-market purchase or sale.
M Holdings Securities Inc. Purchases New Stake in National HealthCare Corporation $NHC
M Holdings Securities Inc. has acquired a significant new stake in National HealthCare Corporation (NYSEAMERICAN:NHC), purchasing 463,194 shares valued at approximately $56.28 million. This makes NHC the second-largest holding in M Holdings Securities Inc.'s portfolio, representing about 11.9% of its total investments. Other institutional investors like First Trust Advisors and Geode Capital Management LLC also adjusted their holdings, bringing the total institutional ownership of NHC to 56.44%. The company recently declared a quarterly dividend of $0.64 per share.
NHC (NHC): Director exercises 3,140 options and holds 43,302 shares
National Healthcare Corp (NHC) director James Paul Abernathy exercised 3,140 stock options at $55.75 per share, increasing his direct holdings to 43,302 common shares. This transaction was an exercise-and-hold event under the company's 2020 Omnibus Equity Incentive Plan, with no sales reported. Abernathy still retains two additional option grants for 7,500 shares each, expiring in 2029 and 2030.
NHC (NHC) SVP & General Counsel exercises 4,500 stock options
Josh A. McCreary, Senior Vice President & General Counsel of NATIONAL HEALTHCARE CORP (NHC), exercised 4,500 stock options at an exercise price of $90.62 per share on March 4, 2026. To cover the exercise price and tax obligations, 3,202 shares were withheld by the company. Following these transactions, McCreary beneficially owned 12,698 shares of NHC common stock.
NHC SEC Filings - National Health 10-K, 10-Q, 8-K Forms
This page provides access to National HealthCare Corporation (NHC) SEC filings, including annual 10-K reports, quarterly 10-Q earnings, 8-K material event reports, and insider trading forms. NHC's filings detail earnings releases, dividend declarations, executive changes, and lease arrangements, with AI-powered summaries available to highlight key points. The article also provides recent stock information like its market cap and recent insider trading activities.
National HealthCare Corp (NHC) executive exercises options, withholds shares for tax
National HealthCare Corp's Senior VP & CIO, Ben Anderson Sr., exercised multiple stock options on March 4, 2026, as detailed in a Form 4 SEC filing. The company subsequently withheld a portion of the common stock to cover the exercise price and associated tax obligations. After these transactions, Ben Anderson Sr. beneficially owns 19,550.0547 shares of NHC common stock.
The Bull Case For National HealthCare (NHC) Could Change Following Strong 2025 Results And White Oak Acquisition
National HealthCare Corporation reported strong financial results for full-year 2025, with increased revenue and net income, partly driven by higher same-facility revenues and the acquisition of White Oak Manor. These results reinforce the company's investment narrative as a diversified post-acute and senior care operator. While the shares have been rising and may still be undervalued, potential risks include integration challenges from acquisitions and regulatory uncertainties.
NHC Earnings History & Surprises | EPS & Revenue Results | NATIONAL HEALTHCARE CORP (NYSEARCA:NHC)
This article provides a comprehensive overview of NATIONAL HEALTHCARE CORP (NHC) earnings history, including past quarterly EPS and revenue results, analyst estimates, and surprise percentages. It details historical performance, future earnings dates, and quarterly growth trends for both EPS and revenue. The data presented focuses on actual performance against estimates for investors and analysts tracking the company.
NHC exec Vicki Dodson granted 1,082 restricted shares (NYSE: NHC)
Vicki L. Dodson, Senior Vice President of Patient Services at National Healthcare Corp (NHC), has been granted 1,082 restricted shares of common stock. This equity award, which came at no cash cost to her, increases her direct holdings to 11,371.5455 shares. The restricted shares will vest in three equal installments on January 1, 2027, January 1, 2028, and January 1, 2029, encouraging long-term alignment with the company.
NHC (NYSE: NHC) awards 1,458 restricted shares to senior counsel
National Healthcare Corp (NYSE: NHC) awarded 1,458 restricted shares of common stock to Senior VP & General Counsel Josh A. McCreary. These shares will vest in three equal installments on January 1 of 2027, 2028, and 2029. Following this grant, McCreary directly holds 11,400 common shares and several option awards.
National Healthcare (NHC) CFO receives 1,507-share restricted stock grant
National Healthcare Corp's SVP and CFO, Brian F. Kidd, was granted 1,507 restricted shares of common stock at $0.00 per share, increasing his direct holdings to 25,224 shares. These shares will vest over three years, with equal portions vesting on January 1st, 2027, 2028, and 2029. The filing also details his existing derivative security holdings, including various options to purchase common stock.
National Healthcare (NHC: NHC) CEO receives 3,090-share restricted grant
National Healthcare Corp's CEO, Stephen Fowler Flatt, was granted 3,090 restricted shares of common stock on February 27, 2026. These shares are subject to a three-year vesting schedule, with equal installments vesting on January 1st of 2027, 2028, and 2029. The filing also detailed several option-to-purchase-common-stock positions held by Flatt.
NHC (NHC) CEO exercises 5,000 options and withholds shares for taxes
National Healthcare Corp's CEO, Stephen Fowler Flatt, exercised options to acquire 5,000 shares of common stock on March 2, 2026. As part of this transaction, 3,585 shares were withheld by the company to cover tax obligations at a price of $171.15 per share. After these transactions, Flatt directly holds 63,652 common shares, and his option positions were updated with various grants under the 2020 Omnibus Equity Incentive Plan.
NHC (NHC) CIO awarded 1,342 restricted shares vesting through 2029
NHC's Senior VP and CIO, Ben Anderson Flatt Sr., was granted 1,342 restricted shares of common stock on February 27, 2026. These shares, valued at $0.00 each, will vest in three equal annual installments starting January 1, 2027, through January 1, 2029. This award increases his direct holdings to 15,459.0547 shares and represents equity compensation rather than a market transaction.
National HealthCare: Q4 Earnings Snapshot
National HealthCare Corp. (NHC) reported Q4 net income of $24.8 million, or $1.58 per share, with adjusted earnings of $1.83 per share. The company's revenue for the quarter was $386.5 million. For the full year, NHC posted a profit of $120 million on revenue of $1.52 billion.
National HealthCare Corp. Experiences Revision in Its Stock Evaluation Amid Strong Performance Metrics
National HealthCare Corp. has seen its stock valuation adjusted, showing a P/E ratio of 20 and a price-to-book value of 1.87. The company boasts a high dividend yield of 50.37% and a ROCE of 16.69%, indicating strong operational efficiency. Its stock performance has significantly outperformed the S&P 500 both year-to-date and over the past year, with returns of 16.84% and 72.97% respectively.
National HealthCare Corp stock hits all-time high of 171.95 USD
National HealthCare Corp (NHC) stock reached a new all-time high of $171.95, representing a 79.74% 1-year change and reflecting strong investor confidence. The company, with a $2.63 billion market cap, has consistently raised its dividend for 12 consecutive years and recently declared a quarterly dividend of 64 cents per common share. InvestingPro analysis suggests the stock remains undervalued, indicating potential for further growth.
NATIONAL HEALTHCARE CORP (NHC) director William A. Adams files Form 3
William A. Adams, a newly appointed director of NATIONAL HEALTHCARE CORP (NHC), has filed an initial statement of beneficial ownership on Form 3 with the SEC. This filing establishes his reporting obligations for future insider transactions but does not indicate any current purchases or sales of company stock. The Form 3 is important for investors as it identifies a new insider whose future stock activities will be publicly disclosed.
National HealthCare (NYSE: NHC) outlines 2025 footprint, payor mix and key risks
National HealthCare Corporation (NHC) detailed its 2025 operations, revealing a broad post-acute and senior care platform across nine states with strong skilled nursing occupancy and quality ratings. The company provided its payer mix, showing significant reliance on Medicare and Medicaid, and highlighted key risks including reimbursement changes, a material lease dispute with National Health Investors, and labor shortages. Despite challenges, NHC continues to expand through acquisitions and manage its diverse services.
National HealthCare Corp. Q4 & Annual Earnings: Revenue Hits $1.52B - News and Statistics
National HealthCare Corp. announced its financial results for the fourth quarter and the full year, with quarterly net income of $24.8 million ($1.58 per share) and adjusted earnings of $1.83 per share. Quarterly revenue reached $386.5 million. For the entire year, the company reported a profit of $120 million ($7.67 per share) and annual revenue of $1.52 billion.
Decoding National Healthcare Corp (NHC): A Strategic SWOT Insigh
National Healthcare Corp's 2025 annual 10-K report reveals its strengths in diversified care services and strong inpatient segment, along with strategic expansion through acquisitions. However, the company faces weaknesses due to competitive pressures and regulatory challenges in the healthcare industry. Opportunities lie in further acquisitions and the increasing demand for senior healthcare services, while threats include an intensifying competitive landscape and changes in patient and payor mix.
NATIONAL HEALTHCARE CORP (NHC) grants 14,000 stock options to exec
NATIONAL HEALTHCARE CORP (NHC) granted its Sr. VP of Operations, Timothy J. Shelly, 14,000 stock options on February 23, 2026, under the company’s 2020 Omnibus Equity Incentive Plan. The options have an exercise price of $0.0000 per share and will vest ratably over three years, with one-third vesting each year on February 23rd, from 2027 to 2029. This transaction was reported in an SEC Form 4 filing on February 25, 2026.
National HealthCare 2025 adjusted profit jumps 35% on White Oak deal, revenue up
National HealthCare Corporation announced a significant increase in its 2025 financial results, driven by strong revenue growth and the acquisition of White Oak Manor. Net operating revenues and grant income rose by 16.1% to over $1.5 billion, while adjusted net income saw a substantial 35.4% increase. The White Oak acquisition, adding 22 healthcare operations, was a key contributor to this growth.
[Form 4] NATIONAL HEALTHCARE CORP Insider Trading Activity
NATIONAL HEALTHCARE CORP (NHC) Senior VP & General Counsel Josh A. McCreary was granted 14,000 stock options on February 23, 2026, with an exercise price of $0.00. These options, granted under the 2020 Omnibus Equity Incentive Plan, will vest in three equal installments on February 23, 2027, 2028, and 2029. The transaction is exempt from Section 16(b) under Rule 16b-3(d).
National HealthCare (NHC) expands board, appoints Gifford and Adams as directors
National HealthCare Corporation (NHC) has expanded its Board of Directors from seven to nine members, appointing Dr. David Gifford and Andrew Adams as independent directors, effective February 12, 2026. Dr. Gifford brings expertise in geriatrics and public health, while Adams contributes experience in long-term care administration and financial services. Both new directors will serve on key committees and will be nominated for three-year terms in upcoming annual meetings.
NHC Announces Common Dividend
National HealthCare Corporation (NHC) announced a quarterly dividend of 64 cents per common share, payable on April 30, 2026, to shareholders of record on March 31, 2026. The company, which is the nation's oldest publicly traded long-term health care company, also highlighted its diverse operations including skilled nursing, assisted living, independent living communities, and various health services. NHC included forward-looking statements and risk factors associated with its financial performance and operations.
National HealthCare Corp Announces Quarterly Dividend
National HealthCare Corp has announced a quarterly dividend of 64 cents per share. This dividend is set for March 31, 2026, with payment scheduled for April 30, 2026, to all shareholders. The announcement reflects NHC's ongoing commitment to providing value to its investors and maintaining its tradition as a prominent long-term care provider.
Nation's oldest long-term health care stock to pay 64¢ a share
National HealthCare Corporation (NHC), the oldest publicly traded long-term healthcare company in the U.S., announced a quarterly dividend of 64 cents per common share. The dividend will be paid to shareholders of record on March 31, 2026, with payment scheduled for April 30, 2026. NHC also provided forward-looking statements and an overview of its extensive operations, which include skilled nursing facilities, assisted living communities, behavioral health hospitals, and homecare/hospice agencies.
National HealthCare Corp stock hits all-time high at 163.18 USD
National HealthCare Corp (NHC) stock has reached an all-time high of $163.18, marking a 65.77% increase over the past year. The company showcases robust performance with 22.67% revenue growth and a "GREAT" financial health rating from InvestingPro, while also offering a 1.58% dividend yield. Despite being potentially overvalued, this milestone reflects strong investor confidence and strategic success in the healthcare sector.
National HealthCare Corp stock hits all-time high at 163.18 USD
National HealthCare Corp (NHC) stock has reached an all-time high of 163.18 USD, driven by a 65.77% increase over the past year and strong investor confidence. Despite being slightly overvalued according to InvestingPro, the company boasts impressive revenue growth of 22.67%, a "GREAT" financial health rating, and a consistent 1.58% dividend yield for 22 consecutive years. This milestone highlights NHC's robust performance and market position within the healthcare sector.
National HealthCare Corp stock hits all-time high at 146.95 USD By Investing.com
National HealthCare Corp (NHC) stock has reached an all-time high of $146.95, driven by a 44.44% increase over the past year and a 52.83% gain in the last six months, alongside robust revenue growth and consistent dividend payments for 22 years. InvestingPro analysis indicates the stock is trading near its Fair Value. The company recently announced a quarterly dividend of 64 cents per common share, further highlighting its commitment to shareholder value.
National HealthCare Corp stock hits all-time high at 146.95 USD
National HealthCare Corp (NHC) stock has reached an all-time high of $146.95, reflecting a 44.44% increase over the past year and a 52.83% gain in the last six months. The company's strong financial performance, including 22.67% revenue growth and 22 consecutive years of dividend payments, has contributed to investor confidence. InvestingPro analysis suggests the stock is currently trading near its Fair Value, and the company recently announced a quarterly dividend of 64 cents per common share.
National HealthCare Corp stock hits all-time high at 146.95 USD
National HealthCare Corp (NHC) stock reached an all-time high of $146.95, reflecting a significant 44.44% increase over the past year and 52.83% over six months. The company's strong performance is attributed to 22.67% revenue growth, a consistent dividend record of 22 years (current yield 1.79%), and moderate debt levels. Investors can anticipate a quarterly dividend of 64 cents per share, payable on January 30, 2026, to shareholders of record by December 31, 2025.
National HealthCare Corp stock hits all-time high at 146.95 USD
National HealthCare Corp (NHC) stock reached an all-time high of 146.95 USD, driven by a 44.44% increase over the past year and impressive financial results including 22.67% revenue growth. The company also announced a quarterly dividend of 64 cents per common share, maintaining a consistent dividend track record. InvestingPro analysis suggests the stock is currently trading at approximately its Fair Value, highlighting its financial strength and moderate debt levels.
National HealthCare Corp stock hits all-time high at 145.04 USD
National HealthCare Corp (NHC) stock has reached an all-time high of 145.04 USD, reflecting a strong performance with a 52.01% one-year total return. The company boasts a market capitalization of $2.23 billion, a P/E ratio of 22.13, and consistently pays dividends, showcasing its financial health and growth potential. Additionally, NHC recently declared a quarterly dividend of 64 cents per common share, payable on January 30, 2026, to shareholders of record on December 31, 2025.
National HealthCare Corp stock hits all-time high at 145.04 USD
National HealthCare Corp (NHC) stock reached an all-time high of $145.04, reflecting a strong performance with a 52.01% one-year total return and a 50.94% gain in the last six months. The company boasts a market capitalization of $2.23 billion, a P/E ratio of 22.13, and robust revenue growth of 22.67%, maintaining dividend payments for 22 consecutive years. Additionally, National HealthCare Corporation recently announced a quarterly dividend of 64 cents per common share, payable on January 30, 2026, to shareholders of record on December 31, 2025.
National HealthCare Corp stock hits all-time high at 145.04 USD By Investing.com
National HealthCare Corp (NHC) stock reached an all-time high of $145.04, reflecting a strong performance with a 52.01% one-year total return and a 50.94% gain in the last six months. With a market cap of $2.23 billion and a P/E ratio of 22.13, the company shows robust financial health and consistent dividend payments for 22 years. NHC recently announced a quarterly dividend of 64 cents per common share, payable on January 30, 2026.
National HealthCare Corp stock hits all-time high at 145.04 USD
National HealthCare Corp (NHC) stock reached an all-time high of 145.04 USD, following a 52.01% total return over the past year and a 50.94% gain in the last six months. The company boasts a market capitalization of $2.23 billion, a P/E ratio of 22.13, and strong revenue growth, with consistent dividend payments for 22 consecutive years. This achievement highlights NHC's robust performance and commitment to shareholder returns within the healthcare sector.
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of National HealthCare Corporation (NYSE: NHC) and Encourages NHC Shareholders to Contact the Firm
Kaskela Law LLC has initiated an investigation into National HealthCare Corporation (NYSE: NHC) to determine if the company, its officers, or directors violated securities laws or breached fiduciary duties. The firm encourages NHC shareholders to contact them for more information regarding this investigation and their legal options. This alert highlights potential corporate misconduct and invites affected investors to seek legal counsel.
SG Americas Securities LLC Buys New Position in National HealthCare Co. $NHC
SG Americas Securities LLC has acquired a new stake in National HealthCare Co. (NYSE:NHC), purchasing 9,602 shares valued at approximately $1.17 million. This move makes SG Americas Securities LLC a 0.06% owner of the company, while institutional investors collectively hold 56.44% of NHC stock. The article also notes a recent insider sale by VP Timothy J. Shelly and outlines National HealthCare's financial performance and company profile.
National HealthCare (NYSEAMERICAN:NHC) Stock Crosses Above Two Hundred Day Moving Average - Here's Why
National HealthCare Corporation (NHC) stock recently surpassed its two hundred day moving average, trading at $139.01 with a 200-day average of $119.74. The company reported strong financials including quarterly EPS of $1.58 and revenue of $382.66 million, and declared a quarterly dividend of $0.64, translating to a 1.8% yield. NHC, which specializes in long-term care and post-acute rehabilitation, currently holds a "Hold" rating from analysts, though some analysts recommend other stocks as better buys.
National HealthCare (NYSEAMERICAN:NHC) Stock Crosses Above Two Hundred Day Moving Average - Here's Why
National HealthCare (NYSEAMERICAN:NHC) stock recently crossed above its 200-day moving average, trading at $131.93 on a volume of 73,426 shares. The company reported EPS of $1.58 on $382.66 million in revenue and declared a quarterly dividend of $0.64, with an annualized yield of 1.9%. NHC specializes in long-term care and post-acute rehabilitation services, operating skilled nursing facilities, assisted living communities, and outpatient therapy clinics.
Pacer Advisors Inc. Trims Stock Position in National HealthCare Co. $NHC
Pacer Advisors Inc. reduced its stake in National HealthCare Co. (NYSE:NHC) by 13.1% in the third quarter, selling 7,732 shares and ending with 51,204 shares valued at $6.22 million. Despite this trimming, several other institutional investors, including Geode Capital Management and Bank of New York Mellon Corp, increased their holdings, contributing to an overall institutional ownership of 56.44%. Meanwhile, VP Timothy J. Shelly disclosed an insider sale of 2,454 shares for approximately $342,137.
National HealthCare (NHC): Reassessing Valuation After Outperform Rating Reaffirmed Despite Recent Insider Share Sale
National HealthCare (NHC) recently had its Outperform rating reaffirmed due to strong financial results and a positive technical setup, despite a recent insider share sale. The company's stock is trading near record highs, showing significant year-to-date and three-year returns, leading to a debate about whether its current market price fully reflects its growth potential. One narrative suggests NHC is undervalued with a fair value of $179.8, presenting a potential entry point for investors.
National Healthcare Corp stock hits all-time high at 141.08 USD
National Healthcare Corp stock has reached an all-time high of 141.08 USD, marking an impressive 35.91% gain over six months and 31.14% year-to-date. This surge is backed by a strong "GREAT" financial health rating and 22.67% revenue growth, alongside a 22-year dividend payment streak. The company recently declared a quarterly dividend of 64 cents per common share, further underscoring its commitment to shareholder value and financial stability.
National Healthcare Corp stock hits all-time high at 141.08 USD
National Healthcare Corp (NHC) stock has reached an all-time high of $141.08 USD, reflecting a 35.91% gain over six months and 31.14% year-to-date. InvestingPro data indicates strong performance, a "GREAT" financial health rating, and the stock is considered slightly undervalued. The company also declared a quarterly dividend of 64 cents per common share, continuing its 22-year dividend payment streak.
